Table 2.
Baseline demographic and clinical characteristics of the cohort of patients enrolled in the study.
| Total populationaN = 58 | |
|---|---|
| Sex, N (%) | |
| Female | 30 (51.7) |
| Male | 25 (43.1) |
| Age at the time of surgery, years median (Q1–Q3) | 63 (50.5–72) |
| Family history of malignancy, N (%) | |
| Yes | 8 (13.8) |
| No | 47 (81.0) |
| Smoking habit, N (%) | |
| Yes | 20 (34.5) |
| No | 35 (60.3) |
| Alcohol consumption N (%) | |
| Yes | 6 (10.3) |
| No | 49 (84.5) |
| Cancer stage according to AJCC Staging System 7th edition, N (%) | |
| Stage IIA, IIB, or IIC | 17 (29.3) |
| Stage IIIA, IIIB, or IIIC | 25 (43.1) |
| Stage IVA or IVB | 13 (22.4) |
| Cancer location, N (%) | |
| Right colon | 11 (19.0) |
| Left colon | 44 (75.9) |
| Cancer histology according to the WHO classification, N (%) | |
| Adenocarcinoma | 55 (94.8) |
| Chemotherapy, N (%) | |
| Yes | 20 (34.5) |
| No | 35 (60.3) |
a
For three patients (5.2%), there was no information available. Q1, first quartile; Q3, third quartile; AJCC, American Joint Committee on Cancer; WHO, World Health Organization.